Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet--NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial

Balayssac, David; Ferrier, Jérémy; Pereira, Bruno; Gillet, Brigitte; Pétorin, Caroline; Vein, Julie; Libert, Frédéric; Eschalier, Alain; Pezet, Denis
April 2015
BMJ Open;Apr2015, Vol. 5 Issue 4, p1
Academic Journal
No abstract available.


Related Articles

  • Radix Astragali-Based Chinese Herbal Medicine for Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Deng, Bo; Jia, Liqun; Cheng, Zhiqiang // Evidence-based Complementary & Alternative Medicine (eCAM);10/4/2016, p1 

    Background. Treatment of chemotherapy-induced peripheral neuropathy (CIPN) remains a big challenge for oncologists. The aim of this study is to evaluate the effects of Radix Astragali- (RA-) based Chinese herbal medicine in the prevention and treatment of oxaliplatin-induced peripheral...

  • Mindfulness for depression.  // Therapy Today;May2015, Vol. 26 Issue 4, p6 

    The article reports that as per single-blind, parallel, group randomised controlled trial (PREVENT), mindfulness-based cognitive therapy (MBCT) act as antidepressants and is more effective in reducing risk of relapse and recurrence of depression.

  • Warming Limbs Eases Insertion of Intravenous Line. Walling, Anne D. // American Family Physician;1/15/2003, Vol. 67 Issue 2, p401 

    Discusses the study 'Local Warming and Insertion of Peripheral Venous Cannulas: Single Blinded Prospective Randomised Controlled Trial and Single Blinded Randomised Crossover Trial,' by R. Lenhardt et al., from the August 24, 2002 issue of the 'British Medical Journal.'

  • A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Schloss, Janet; Colosimo, Maree; Airey, Caroline; Masci, Paul; Linnane, Anthony; Vitetta, Luis; Schloss, Janet M; Linnane, Anthony W // Supportive Care in Cancer;Jan2017, Vol. 25 Issue 1, p195 

    Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side effect resulting from neurotoxic chemotherapeutic agents. This study aimed to assess the efficacy and safety of an oral B group vitamin compared to placebo, in preventing the incidence of CIPN in...

  • MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy. Zimmerman, Collin; Atherton, Pamela; Pachman, Deirdre; Seisler, Drew; Wagner-Johnston, Nina; Dakhil, Shaker; Lafky, Jacqueline; Qin, Rui; Grothey, Axel; Loprinzi, Charles; Atherton, Pamela J; Lafky, Jacqueline M; Loprinzi, Charles L // Supportive Care in Cancer;Mar2016, Vol. 24 Issue 3, p1071 

    Purpose: Previous pilot data suggested that venlafaxine could prevent acute and chronic oxaliplatin-related neuropathy. The purpose of this randomized, placebo-controlled, double-blinded pilot study was to obtain additional data to support conducting a phase III trial to test the...

  • Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats. Kono, Toru; Suzuki, Yasuyuki; Mizuno, Keita; Miyagi, Chika; Omiya, Yuji; Sekine, Hitomi; Mizuhara, Yasuharu; Miyano, Kanako; Kase, Yoshio; Uezono, Yasuhito // Scientific Reports;11/6/2015, p16078 

    Oxaliplatin, a widely used chemotherapeutic agent, induces peripheral neuropathy that manifests itself as two distinct phases: acute cold hyperesthesia and chronic peripheral hypoesthesia/dysesthesia. The latter is a serious dose-limiting side effect that can often lead to withdrawal of...

  • Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy. White, Claire M.; Hadden, Robert D.; Robert-Lewis, Sarah F.; McCrone, Paul R.; Petty, Jane L. // BMC Neurology;Aug2015, Vol. 15 Issue 1, p1 

    Background: Inflammatory neuropathies such as Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and paraproteinaemic demyelinating neuropathy are a heterogenous group of peripheral nerve disorders that affect around one to two people per 100,000. Whilst...

  • Erratum to: Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV. Vincenzi, Bruno; Frezza, Anna; Schiavon, Gaia; Spoto, Chiara; Silvestris, Nicola; Addeo, Raffaele; Catalano, Vincenzo; Graziano, Francesco; Santini, Daniele; Tonini, Giuseppe // Supportive Care in Cancer;Apr2013, Vol. 21 Issue 4, p1209 

    A correction to the article "Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV" that was published in the January 25, 2013 issue is presented.

  • Third stage of labour. White, Adrian; Langweiler, Mark; Meinen, Michael // Acupuncture in Medicine;Jun2015, Vol. 33 Issue 3, p242 

    The article discusses the study "Influence of Acupuncture on the Third Stage of Labor: A Randomised Controlled Trial" which appeared in a 2015 issue of the "Journal of Midwifery and Women's Health." Topics include subjects included in a single-blind randomised trial, reasons that only 76 women...

  • Impact of oxaliplatin-induced neuropathy in patients with colorectal cancer: a prospective evaluation at a single institution. Dault, R.; Rousseau, M. P.; Beaudoin, A.; Frenette, M. A.; Lemay, F.; Beauchesne, M. F. // Current Oncology;Feb2016, Vol. 23 Issue 1, pe65 

    Oxaliplatin plays a major role in the treatment of colorectal cancer (CRC), but is associated with the development of neuropathies. The main objective of the present prospective study was to estimate the proportion of participants with grade 1, 2, 3, or 4 peripheral sensory neuropathies...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics